WMS Group LLC lessened its stake in shares of Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Free Report) by 60.4% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 59,416 shares of the company’s stock after selling 90,439 shares during the period. Invesco Nasdaq Biotechnology ETF accounts for 2.5% of WMS Group LLC’s holdings, making the stock its 16th largest position. WMS Group LLC’s holdings in Invesco Nasdaq Biotechnology ETF were worth $1,722,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Breakwater Capital Group bought a new stake in Invesco Nasdaq Biotechnology ETF during the 1st quarter worth about $200,000. Osaic Holdings Inc. raised its position in shares of Invesco Nasdaq Biotechnology ETF by 66.1% during the 4th quarter. Osaic Holdings Inc. now owns 7,989 shares of the company’s stock valued at $227,000 after acquiring an additional 3,178 shares during the last quarter. Royal Bank of Canada acquired a new position in Invesco Nasdaq Biotechnology ETF in the fourth quarter valued at about $37,000. CreativeOne Wealth LLC bought a new position in Invesco Nasdaq Biotechnology ETF during the 4th quarter worth approximately $286,000. Finally, Orion Porfolio Solutions LLC acquired a new position in shares of Invesco Nasdaq Biotechnology ETF in the 4th quarter valued at $392,000.
Invesco Nasdaq Biotechnology ETF Stock Up 2.3%
Invesco Nasdaq Biotechnology ETF stock opened at $32.23 on Friday. The company has a 50 day moving average of $29.65 and a 200-day moving average of $29.24. The stock has a market capitalization of $72.84 million, a PE ratio of 17.03 and a beta of 0.62. Invesco Nasdaq Biotechnology ETF has a twelve month low of $21.05 and a twelve month high of $32.37.
Invesco Nasdaq Biotechnology ETF Dividend Announcement
About Invesco Nasdaq Biotechnology ETF
The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.
See Also
- Five stocks we like better than Invesco Nasdaq Biotechnology ETF
- Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
- AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
- Palantir’s Valuation Problem Just Met 2 New Growth Catalysts
- Xcel Energy Stock Offers Stability as Electricity Demand Builds
Want to see what other hedge funds are holding IBBQ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Free Report).
Receive News & Ratings for Invesco Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.
